quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:13:50·129d
SECFiling
Abivax SA logo

SEC Form 6-K filed by Abivax SA

ABVX· Abivax SA
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • ABVX
    Abivax SA
    Health Care

Recent analyst ratings

  • Mar 16UpdateJefferies$160.00
  • Feb 24UpdateWedbush$110.00
  • Nov 24UpdateTruist-
  • Nov 6UpdateWolfe Research$176.00
  • Oct 13UpdateBarclays$142.00
  • Jul 23UpdateMorgan Stanley$71.00

Related

  • PR1d
    Abivax to Present Data on Obefazimod at Digestive Disease Week®
  • SEC3d
    SEC Form 6-K filed by Abivax SA
  • PR3d
    Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
  • PR22d
    Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
  • SEC31d
    SEC Form S-8 filed by Abivax SA
  • SEC31d
    SEC Form 20-F filed by Abivax SA
  • SEC31d
    SEC Form 6-K filed by Abivax SA
  • PR31d
    Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022